RecruitingNCT00669266

Adrenal Tumors - Pathogenesis and Therapy

Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

Sponsor

University of Wuerzburg

Enrollment

500 participants

Start Date

Sep 1, 2002

Study Type

OBSERVATIONAL

Conditions

Pheochromocytoma Adrenocortical Carcinoma Cushing Syndrome Conn Syndrome Adrenal Tumors

Summary

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

Eligibility

Max Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study investigates the causes of adrenal tumors (both benign and malignant growths on the adrenal glands, which sit above the kidneys and produce important hormones) and evaluates different treatment approaches. **You may be eligible if...** - You have been diagnosed with an adrenal tumor (including adrenal adenoma, pheochromocytoma, or adrenocortical carcinoma) - You are willing to provide blood, urine, and tissue samples for analysis - You are 18 years of age or older **You may NOT be eligible if...** - You have a different, non-adrenal cause for your symptoms - You are unable or unwilling to provide informed consent - You are not being treated at a participating institution Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.